According to Palatin Technologies's latest financial reports the company's current EPS (TTM) is S-$1.57. In 2022 the company made an earnings per share (EPS) of S-$3.54 an increase over its 2021 EPS that were of S-$4.71.
Year | EPS | Change |
---|---|---|
2025 (TTM) | S-$1.62 | |
2022 | S-$3.54 | -24.86% |
2021 | S-$4.71 | 33.09% |
2020 | S-$3.54 | |
2014 | S-$0.32 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() MediciNova MNOV | S-$0.30 | -81.15% | ๐บ๐ธ USA |
![]() GlycoMimetics
GLYC | S-$0.67 | -57.38% | ๐บ๐ธ USA |
![]() Neurocrine Biosciences
NBIX | S$3.90 | -348.36% | ๐บ๐ธ USA |
![]() ANI Pharmaceuticals ANIP | S-$1.62 | 3.28% | ๐บ๐ธ USA |
![]() Ligand Pharmaceuticals LGND | S-$9.17 | 483.61% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | S$11.68 | -843.25% | ๐บ๐ธ USA |
![]() Ardelyx ARDX | S-$0.21 | -86.60% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | S$3.23 | -305.33% | ๐ฌ๐ง UK |